UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

VLSI implementation of MIMO detection using the sphere decoding algorithm

IEEE journal of solid-state circuits, 2005-07, Vol.40 (7), p.1566-1577

2005

Volltextzugriff (PDF)

A Psychometric Study of a Trait and State Assessment of Sexual Pleasure – The Amsterdam Sexual Pleasure Inventory

The Journal of sex research, 2023-11, p.1-27

2023

Volltextzugriff (PDF)

Impact of the propagation environment on the performance of space-frequency coded MIMO-OFDM

IEEE journal on selected areas in communications, 2003-04, Vol.21 (3), p.427-439

2003

Volltextzugriff (PDF)

Novel Approach of MALDI Drug Imaging, Immunohistochemistry, and Digital Image Analysis for Drug Distribution Studies in Tissues

Analytical chemistry (Washington), 2014-11, Vol.86 (21), p.10568-10575

2014

Volltextzugriff (PDF)

Resminostat, a new treatment option in cutaneous T cell lymphoma (CTCL)

European journal of cancer (1990), 2016-12, Vol.69, p.S88-S89

2016

Volltextzugriff (PDF)

Resminostat sensitizes hepatocellular carcinoma cells to sorafenib-induced cell death

European journal of cancer (1990), 2016-12, Vol.69, p.S87-S87

2016

Volltextzugriff (PDF)

Noncoherent space-frequency coded MIMO-OFDM

IEEE journal on selected areas in communications, 2005-09, Vol.23 (9), p.1799-1810

2005

Volltextzugriff (PDF)

Depression and epilepsy : Two clinical pictures with common causes?

Nervenarzt, 2016-07, Vol.87 (7), p.724-730

2016

Volltextzugriff (PDF)

179 Bringing Light into Antibody Binding Characteristics in Crude Extracts by Means of FCCS

European journal of cancer (1990), 2012-11, Vol.48, p.54-54

2012

Volltextzugriff (PDF)

PO-455 Epigenetic insights: resminostat regulates targets associated with the pathogenesis of cutaneous T cell lymphoma (CTCL)

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A200-A201

2018

Volltextzugriff (PDF)

Single Molecule Fluorescence Microscopy and Machine Learning for Rhesus D Antigen Classification

Scientific reports, 2016-09, Vol.6 (1), p.32317-32317, Article 32317

2016

Volltextzugriff (PDF)

Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients

Journal of thermal analysis and calorimetry, 2009-08, Vol.97 (2), p.729-733

2009

Volltextzugriff (PDF)

Terbinafine: optimization of a LC method for quantitative analysis in pharmaceutical formulations and its application for a tablet dissolution test

Química Nova, 2010, Vol.33 (8), p.1790-1793

2010

Volltextzugriff (PDF)

Depression und Epilepsie: Zwei Krankheitsbilder mit gemeinsamen Ursachen?

Nervenarzt, 2016-07, Vol.87 (7), p.724-730

2016

Volltextzugriff (PDF)

027 - Transcriptional impact of resminostat and other HDAC inhibitors on disease-related gene expression in CTCL

European journal of cancer (1990), 2019, Vol.119, p.S10-S10

2019

Volltextzugriff (PDF)

106 - HDACi resminostat causes a sustained reduction of the pruritus mediator IL-31 in CTCL cells

European journal of cancer (1990), 2019, Vol.119, p.S38-S38

2019

Volltextzugriff (PDF)

HDACi resminostat causes a sustained reduction of the pruritus mediator IL-31 in CTCL cells

European journal of cancer (1990), 2019, Vol.119, p.S38

2019

Volltextzugriff (PDF)

Transcriptional impact of resminostat and other HDAC inhibitors on disease-related gene expression in CTCL

European journal of cancer (1990), 2019, Vol.119, p.S10

2019

Volltextzugriff (PDF)

Development and Validation of a Stability-Indicating LC Method for the Determination of Venlafaxine in Extended-Release Capsules and Dissolution Kinetic Studies

Journal of chromatographic science, 2009-10, Vol.47 (9), p.770-776

2009

Volltextzugriff (PDF)

261 - Resminostat sensitizes hepatocellular carcinoma cells to sorafenib-induced cell death

European journal of cancer (1990), 2016-12, Vol.69, p.S87-S87

2016

Volltextzugriff (PDF)

007 - Resminostat increases NK cell-mediated lysis of malignant cells beneficially affecting the function of opsonizing antibodies

European journal of cancer (1990), 2019, Vol.119, p.S3-S3

2019

Volltextzugriff (PDF)

Resminostat increases NK cell-mediated lysis of malignant cells beneficially affecting the function of opsonizing antibodies

European journal of cancer (1990), 2019, Vol.119, p.S3

2019

Volltextzugriff (PDF)

088 - A multicenter, d ouble blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study

European journal of cancer (1990), 2019, Vol.119, p.S32-S32

2019

Volltextzugriff (PDF)

A multicenter, d ouble blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study

European journal of cancer (1990), 2019, Vol.119, p.S32

2019

Volltextzugriff (PDF)

Prediction of Mechanisms of Action of Antibacterial Compounds by Gene Expression Profiling

Antimicrobial Agents and Chemotherapy, 2004-08, Vol.48 (8), p.2838-2844

2004

Volltextzugriff (PDF)

1 – 25 von 547

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(416)
Mit Volltextzugriff
(448)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

VLSI implementation of MIMO detection using the sphere decoding algorithm

A Psychometric Study of a Trait and State Assessment of Sexual Pleasure – The Amsterdam Sexual Pleasure Inventory

Impact of the propagation environment on the performance of space-frequency coded MIMO-OFDM

Novel Approach of MALDI Drug Imaging, Immunohistochemistry, and Digital Image Analysis for Drug Distribution Studies in Tissues

Resminostat, a new treatment option in cutaneous T cell lymphoma (CTCL)

Resminostat sensitizes hepatocellular carcinoma cells to sorafenib-induced cell death

Noncoherent space-frequency coded MIMO-OFDM

Depression and epilepsy : Two clinical pictures with common causes?

179 Bringing Light into Antibody Binding Characteristics in Crude Extracts by Means of FCCS

PO-455 Epigenetic insights: resminostat regulates targets associated with the pathogenesis of cutaneous T cell lymphoma (CTCL)

Single Molecule Fluorescence Microscopy and Machine Learning for Rhesus D Antigen Classification

Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients

Terbinafine: optimization of a LC method for quantitative analysis in pharmaceutical formulations and its application for a tablet dissolution test

Depression und Epilepsie: Zwei Krankheitsbilder mit gemeinsamen Ursachen?

027 - Transcriptional impact of resminostat and other HDAC inhibitors on disease-related gene expression in CTCL

106 - HDACi resminostat causes a sustained reduction of the pruritus mediator IL-31 in CTCL cells

HDACi resminostat causes a sustained reduction of the pruritus mediator IL-31 in CTCL cells

Transcriptional impact of resminostat and other HDAC inhibitors on disease-related gene expression in CTCL

Development and Validation of a Stability-Indicating LC Method for the Determination of Venlafaxine in Extended-Release Capsules and Dissolution Kinetic Studies

261 - Resminostat sensitizes hepatocellular carcinoma cells to sorafenib-induced cell death

007 - Resminostat increases NK cell-mediated lysis of malignant cells beneficially affecting the function of opsonizing antibodies

Resminostat increases NK cell-mediated lysis of malignant cells beneficially affecting the function of opsonizing antibodies

A multicenter, d ouble blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study

Prediction of Mechanisms of Action of Antibacterial Compounds by Gene Expression Profiling

Suchergebnisse filtern